- $20.73m
- $17.23m
- $8.27m
- 45
- 59
- 82
- 65
Annual balance sheet for Trxade Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-Q | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 2.87 | 5.92 | 3.12 | 1.09 | 0.152 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.792 | 1.89 | 0.979 | 0.649 | 2.49 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.8 | 9.22 | 4.37 | 2.09 | 2.75 |
Net Property, Plant And Equipment | 0.933 | 0.55 | 1.33 | 1.12 | 0.807 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 5.57 | 9.79 | 5.77 | 3.71 | 12.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.521 | 0.842 | 0.926 | 2.15 | 11.6 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.43 | 1.11 | 2 | 2.95 | 12 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 4.14 | 8.68 | 3.77 | 0.763 | 0.542 |
Total Liabilities & Shareholders' Equity | 5.57 | 9.79 | 5.77 | 3.71 | 12.5 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |